52 related articles for article (PubMed ID: 36494329)
1. Real-World Experience With Deutetrabenazine for Huntington Disease Chorea.
Curtis K; Sung V
J Clin Pharmacol; 2024 Feb; 64(2):178-181. PubMed ID: 37565322
[TBL] [Abstract][Full Text] [Related]
2. Safety of Deutetrabenazine for the Treatment of Tardive Dyskinesia and Chorea Associated with Huntington Disease.
Frank S; Anderson KE; Fernandez HH; Hauser RA; Claassen DO; Stamler D; Factor SA; Jimenez-Shahed J; Barkay H; Wilhelm A; Alexander JK; Chaijale N; Barash S; Savola JM; Gordon MF; Chen M
Neurol Ther; 2024 Jun; 13(3):655-675. PubMed ID: 38557959
[TBL] [Abstract][Full Text] [Related]
3. State-of-the-art pharmacological approaches to reduce chorea in Huntington's disease.
Gibson JS; Claassen DO
Expert Opin Pharmacother; 2021 Jun; 22(8):1015-1024. PubMed ID: 33550875
[No Abstract] [Full Text] [Related]
4. Real-world experience with Deutetrabenazine management in patients with Huntington's disease using video-based telemedicine.
Lin L; Cai M; Su F; Wu T; Yuan K; Li Y; Luo Y; Chen D; Pei Z
Neurol Sci; 2024 May; 45(5):2047-2055. PubMed ID: 37973627
[TBL] [Abstract][Full Text] [Related]
5. Tetrabenazine (Xenazine), An FDA-Approved Treatment Option For Huntington's Disease-Related Chorea.
Yero T; Rey JA
P T; 2008 Dec; 33(12):690-4. PubMed ID: 19750050
[No Abstract] [Full Text] [Related]
6. A new drug to treat chorea in Huntington disease.
Wood H
Nat Rev Neurol; 2023 Jul; 19(7):387. PubMed ID: 37280292
[No Abstract] [Full Text] [Related]
7. Arsenical Treatment of Chorea.
Indep Pract; 1882 Jul; 3(7):477. PubMed ID: 37825538
[No Abstract] [Full Text] [Related]
8. Treatment of Chorea.
Chic Med Exam; 1861 Jan; 2(1):52-53. PubMed ID: 37472589
[No Abstract] [Full Text] [Related]
9. Chorea, Its Nature and Treatment.
Gibbs OC
Med Exam (Phila); 1856 Sep; 12(141):525-536. PubMed ID: 38122034
[No Abstract] [Full Text] [Related]
10. Valbenazine as treatment for Huntington's disease chorea.
Heim B; Seppi K
Lancet Neurol; 2023 Jun; 22(6):459-460. PubMed ID: 37210087
[No Abstract] [Full Text] [Related]
11. Huntington's Disease: Complex Pathogenesis and Therapeutic Strategies.
Tong H; Yang T; Xu S; Li X; Liu L; Zhou G; Yang S; Yin S; Li XJ; Li S
Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612657
[TBL] [Abstract][Full Text] [Related]
12. A proof-of-concept study with SOM3355 (bevantolol hydrochloride) for reducing chorea in Huntington's disease.
Gamez J; Calopa M; Muñoz E; Ferré A; Huertas O; McAllister K; Reig N; Scart-Grès C; Insa R; Kulisevsky J
Br J Clin Pharmacol; 2023 May; 89(5):1656-1664. PubMed ID: 36494329
[TBL] [Abstract][Full Text] [Related]
13. Safety and efficacy of valbenazine for the treatment of chorea associated with Huntington's disease (KINECT-HD): a phase 3, randomised, double-blind, placebo-controlled trial.
Furr Stimming E; Claassen DO; Kayson E; Goldstein J; Mehanna R; Zhang H; Liang GS; Haubenberger D;
Lancet Neurol; 2023 Jun; 22(6):494-504. PubMed ID: 37210099
[TBL] [Abstract][Full Text] [Related]
14. Tetrabenazine: for chorea associated with Huntington's disease.
Scott LJ
CNS Drugs; 2011 Dec; 25(12):1073-85. PubMed ID: 22133328
[TBL] [Abstract][Full Text] [Related]
15. Review of deutetrabenazine: a novel treatment for chorea associated with Huntington's disease.
Dean M; Sung VW
Drug Des Devel Ther; 2018; 12():313-319. PubMed ID: 29497277
[TBL] [Abstract][Full Text] [Related]
16. Deutetrabenazine: A Review in Chorea Associated with Huntington's Disease.
Heo YA; Scott LJ
Drugs; 2017 Nov; 77(17):1857-1864. PubMed ID: 29080203
[TBL] [Abstract][Full Text] [Related]
17. Effect of Deutetrabenazine on Chorea Among Patients With Huntington Disease: A Randomized Clinical Trial.
; Frank S; Testa CM; Stamler D; Kayson E; Davis C; Edmondson MC; Kinel S; Leavitt B; Oakes D; O'Neill C; Vaughan C; Goldstein J; Herzog M; Snively V; Whaley J; Wong C; Suter G; Jankovic J; Jimenez-Shahed J; Hunter C; Claassen DO; Roman OC; Sung V; Smith J; Janicki S; Clouse R; Saint-Hilaire M; Hohler A; Turpin D; James RC; Rodriguez R; Rizer K; Anderson KE; Heller H; Carlson A; Criswell S; Racette BA; Revilla FJ; Nucifora F; Margolis RL; Ong M; Mendis T; Mendis N; Singer C; Quesada M; Paulsen JS; Brashers-Krug T; Miller A; Kerr J; Dubinsky RM; Gray C; Factor SA; Sperin E; Molho E; Eglow M; Evans S; Kumar R; Reeves C; Samii A; Chouinard S; Beland M; Scott BL; Hickey PT; Esmail S; Fung WL; Gibbons C; Qi L; Colcher A; Hackmyer C; McGarry A; Klos K; Gudesblatt M; Fafard L; Graffitti L; Schneider DP; Dhall R; Wojcieszek JM; LaFaver K; Duker A; Neefus E; Wilson-Perez H; Shprecher D; Wall P; Blindauer KA; Wheeler L; Boyd JT; Houston E; Farbman ES; Agarwal P; Eberly SW; Watts A; Tariot PN; Feigin A; Evans S; Beck C; Orme C; Edicola J; Christopher E
JAMA; 2016 Jul; 316(1):40-50. PubMed ID: 27380342
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
